LeonaBio, Inc. (LONA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US04746L2034
LeonaBio, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -102.27 m USD |
| EBIT | -105.61 m USD |
| Net income | -105.61 m USD |
| Diluted EPS – continuing operations | -24.70 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About LeonaBio, Inc.
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company's lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of diabetic neuropathy, which is in phase 1 clinical trial; and ATH-1017 for the treatment of Alzheimer's disease and Parkinson's disease, which is in phase 2 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as Athira Pharma, Inc. and changed its name to LeonaBio, Inc. in January 2026. LeonaBio, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.
More stocks
- HyOrc Corp (HYOR)
- Future FinTech Group Inc. (FTFT)
- PIXELWORKS, INC (PXLW)
- AUTOSCOPE TECHNOLOGIES CORP (AATC)
- Viscount Mining Corp. (VML.V)
- Cohen & Co Inc. (COHN)
- RESERVE PETROLEUM CO (RSRV)
- TuSimple Holdings Inc. (TSPH)
- DMS Propertindo Tbk PT (KOTA.JK)
- Inmune Bio, Inc. (INMB)
- SCYNEXIS INC (SCYX)
- Laser Photonics Corp (LASE)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.